Literature DB >> 2995723

[Growth factors. A new dimension in understanding oncogenesis].

V Heinemann, U Jehn.   

Abstract

The current understanding in biology and function of 4 growth factors is reviewed. PDGF suggests functions for proto-oncogens in normal cells, which may interact in tightly linked hierachies to induce malignant growth. PDGF-requirement of normal fibroblast cell-lines is lost when the cells are infected with tumor viruses. TGF is able to stimulate growth of normally anchorage dependent cells in an anchorage independent manner in soft agar. This ability is thought to be the best in-vitro correlate of neoplastic transformation. The peptide hormones bombesin/gastrin releasing factor and EGF can act as autocrine growth factors in various lung cancer cell-lines and stimulate clonal tumor cell growth in-vitro. The potential clinical application of these types of growth factors may enable the in-vitro growth from any lung cancer patient and allow individual drug testing. TCGF produced by T-cells to activate T-cells, is central to immune stimulation and immune response. Models for potential indirect anticancer effects either by in-vivo administration or by in-vivo incubation plus passive transfer of T-cells are presented to be initiated in future clinical trials.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2995723     DOI: 10.1007/bf01733825

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  42 in total

1.  Growth factors from murine sarcoma virus-transformed cells.

Authors:  J E de Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

2.  Macrophage-independent activation of helper T cells. I. Production of Interleukin 2.

Authors:  J J Farrar; S B Mizel; J Fuller-Farrar; W L Farrar; M L Hilfiker
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

3.  Molecular cloning of gene sequences regulated by platelet-derived growth factor.

Authors:  B H Cochran; A C Reffel; C D Stiles
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

4.  Purification of human platelet-derived growth factor.

Authors:  H N Antoniades; C D Scher; C D Stiles
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

5.  Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity.

Authors:  K Welte; C Y Wang; R Mertelsmann; S Venuta; S P Feldman; M A Moore
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

6.  Interleukin 2 dependence of human natural killer (NK) cell activity.

Authors:  W Domzig; B M Stadler; R B Herberman
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

7.  Interleukin 2-dependent natural killer (NK) cell lines from patients with primary T cell immunodeficiencies.

Authors:  N Flomenberg; K Welte; R Mertelsmann; R O'Reilly; B Dupont
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

8.  Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor.

Authors:  G Carpenter; C M Stoscheck; Y A Preston; J E DeLarco
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

9.  Down regulation of epidermal growth factor receptors: direct demonstration of receptor degradation in human fibroblasts.

Authors:  C M Stoscheck; G Carpenter
Journal:  J Cell Biol       Date:  1984-03       Impact factor: 10.539

10.  125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts.

Authors:  G Carpenter; S Cohen
Journal:  J Cell Biol       Date:  1976-10       Impact factor: 10.539

View more
  2 in total

1.  Biotinylated epidermal growth factor: a useful tool for the histochemical analysis of specific binding sites.

Authors:  K Kayser; G Weisse; H J Gabius; T Hintze
Journal:  Histochem J       Date:  1990-08

2.  "Platelet-Rich Fibrin Membrane-as a novel biomaterial for pressure injury healing in a person with spinal cord injury: A case report".

Authors:  Raktim Swarnakar; Hafis Rahman; Srikumar Venkataraman
Journal:  Spinal Cord Ser Cases       Date:  2022-08-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.